4//SEC Filing
Zeltiq Aesthetics Inc 4
Accession 0001209191-17-028628
CIK 0001415336operating
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 1:56 PM ET
Size
8.2 KB
Accession
0001209191-17-028628
Insider Transaction Report
Form 4
Zavodnick Todd Erik
President, International
Transactions
- Disposition to Issuer
Common Stock
2017-04-28−99,971→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2017-04-28−16,674→ 0 totalExercise: $40.89Exp: 2027-01-17→ Common Stock (16,674 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc. a wholly owned subsidiary of Allergan plc ("Allergan"), Blizzard Merger Sub, Inc. ("Merger Sub"), and the Issuer (the "Merger Agreement"), as approved by the board of directors of the Issuer (the "Board"), whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the "Merger"). In connection with the Merger, the Board accelerated and vested in full all equity awards held by the Reporting Person as of immediately prior to the closing of the Merger. Pursuant to the terms of the Merger Agreement, all 99,971 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes.
- [F2]In connection with the Merger, the Board accelerated and vested in full all equity awards held by the Reporting Person as of immediately prior to the closing of the Merger. Pursuant to the terms of the Merger Agreement, all shares subject to this option were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes.
Documents
Issuer
Zeltiq Aesthetics Inc
CIK 0001415336
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001415336
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 1:56 PM ET
- Size
- 8.2 KB